The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding

被引:70
作者
Barragan, A
Fernandez, V
Chen, QJ
von Euler, A
Wahlgren, M
Spillmann, D
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden
[2] Swedish Inst Infect Dis Control, S-17177 Stockholm, Sweden
[3] Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, Uppsala, Sweden
关键词
D O I
10.1182/blood.V95.11.3594.011k21_3594_3599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), present on the surfaces of parasitized red blood cells (pRBC), mediates resetting, a virulent phenotype, Here, we show that pRBC specifically bind heparan sulfate (HS) and heparin onto their surfaces and that the resetting ligand PfEMP1 specifically adheres to heparin-Sepharose when extracted from the surfaces of radioiodinated infected RBC. An analysis of the binding properties of the different regions of PfEMP1 provides evidence that the Duffy-binding-like domain-1 (DBL-1) is the predominant ligand involved in HS and heparin binding. Soluble DBL-1 requires a minimal heparin fragment size of a 12-mer (approximate to 4 kd) for binding and is critically dependent on N-sulfation. A 12-mer is also the minimal heparin fragment that disrupts naturally formed rosettes. DBL-1 binds specifically to erythrocytes and also to HS from endothelial cells and human aorta but not to chondroitin sulfate A, suggesting that different PfEMP1s mediate adhesion to distinct glycosaminoglycans in individual malaria parasites. Present data suggest that HS on endothelial cells may also be involved in the sequestration of pRBC. Elucidation of these binding mechanisms opens up new possibilities for therapeutic strategies targeting adhesive interactions of pRBC. (Blood. 2000;95:3594-3599) (C) 2000 by The American Society of Hematology.
引用
收藏
页码:3594 / 3599
页数:6
相关论文
共 34 条
[21]   The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1 [J].
Reeder, JC ;
Cowman, AF ;
Davern, KM ;
Beeson, JG ;
Thompson, JK ;
Rogerson, SJ ;
Brown, GV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5198-5202
[22]   Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells [J].
Robert, C ;
Pouvelle, B ;
Meyer, P ;
Muanza, K ;
Fujioka, H ;
Aikawa, M ;
Scherf, A ;
Gysin, J .
RESEARCH IN IMMUNOLOGY, 1995, 146 (06) :383-393
[23]   CHONDROITIN SULFATE A IS A CELL-SURFACE RECEPTOR FOR PLASMODIUM-FALCIPARUM-INFECTED ERYTHROCYTES [J].
ROGERSON, SJ ;
CHAIYAROJ, SC ;
NG, K ;
REEDER, JC ;
BROWN, GV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :15-20
[24]  
Rostand KS, 1997, INFECT IMMUN, V65, P1
[25]   PLASMODIUM-FALCIPARUM - A FAMILY OF SULFATED GLYCOCONJUGATES DISRUPTS ERYTHROCYTE ROSETTES [J].
ROWE, A ;
BERENDT, AR ;
MARSH, K ;
NEWBOLD, CI .
EXPERIMENTAL PARASITOLOGY, 1994, 79 (04) :506-516
[26]   PLASMODIUM-FALCIPARUM ROSETTING IS ASSOCIATED WITH MALARIA SEVERITY IN KENYA [J].
ROWE, A ;
OBEIRO, J ;
NEWBOLD, CI ;
MARSH, K .
INFECTION AND IMMUNITY, 1995, 63 (06) :2323-2326
[27]   P-falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1 [J].
Rowe, JA ;
Moulds, JM ;
Newbold, CI ;
Miller, LH .
NATURE, 1997, 388 (6639) :292-295
[28]   Heparan sulfate: A piece of information [J].
Salmivirta, M ;
Lidholt, K ;
Lindahl, U .
FASEB JOURNAL, 1996, 10 (11) :1270-1279
[29]   Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes [J].
Scholander, C ;
Treutiger, CJ ;
Hultenby, K ;
Wahlgren, M .
NATURE MEDICINE, 1996, 2 (02) :204-208
[30]   SWITCHES IN EXPRESSION OF PLASMODIUM-FALCIPARUM VAR GENES CORRELATE WITH CHANGES IN ANTIGENIC AND CYTOADHERENT PHENOTYPES OF INFESTED ERYTHROCYTES [J].
SMITH, JD ;
CHITNIS, CE ;
CRAIG, AG ;
ROBERTS, DJ ;
HUDSONTAYLOR, DE ;
PETERSON, DS ;
PINCHES, R ;
NEWBOLD, CI ;
MILLER, LH .
CELL, 1995, 82 (01) :101-110